Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion type Assertion NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_head.
- NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion description "[In addition, the genes B7-H1 (p = 0.040), FRA2 (p = 0.035), CD151 (p = 0.004) and BCL2L2 (p = 0.035) showed significantly higher expression in early metastasized than in nonmetastatic tumor samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_provenance.
- NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion evidence source_evidence_literature NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_provenance.
- NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion SIO_000772 21600596 NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_provenance.
- NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion wasDerivedFrom befree-20150227 NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_provenance.
- NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_assertion wasGeneratedBy ECO_0000203 NP298223.RAySpLiPi7qxZScHOEBrmaandU1E6GcOXbKmsGzOs-CLE130_provenance.